课题基金 / 基金详情

Novel therapies for diaphragm failure in muscular dystrophy

Novel therapies for diaphragm failure in muscular dystrophy
肌营养不良症膈肌衰竭的新疗法
批准号:
451388
负责人:
Petrof Basil J
金额:
$66.04万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-09-01 至 2026-09-01

项目摘要

项目成果

Petrof Basil J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Duchenne muscular dystrophy (DMD), the most common genetic muscle disease, is lethal with no cure at this point in time. Most patients succumb to respiratory failure, which is caused by gradual destruction of the diaphragm, the main breathing muscle. The
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the basis of diaphragmatic weakness in critical illness
Novel strategies for treating respiratory muscle failure in muscular dystrophy
Ventilator-induced diaphragmatic dysfunction.
  • 批准号:
    254195
  • 项目类别:
    Operating Grants
  • 资助金额:
    $52.61万
  • 财政年份:
    2012
  • 负责人:
    Petrof Basil J
  • 依托单位:
Strategies for therapy of respiratory muscle failure in muscular dystrophy.
海外基金